ArticleLeukemia2026

A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia.

Sara M A Mohamed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.